Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 11—November 2007

Distribution of Eosinophilic Meningitis Cases Attributable to Angiostrongylus cantonensis, Hawaii

Natasha S. Hochberg*1Comments to Author , Sarah Y. Park†, Brian G. Blackburn*2, James J. Sejvar*, Kate Gaynor‡, Heath Chung§, Karyn Leniek*, Barbara L. Herwaldt*, and Paul V. Effler†
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Hawaii State Department of Health, Honolulu, Hawaii, USA; ‡Centers for Disease Control and Prevention, Honolulu, Hawaii, USA; §University of Hawaii School of Medicine, Honolulu, Hawaii, USA;

Main Article

Table 1

Case definitions for eosinophilic meningitis (EM) and Angiostrongylus cantonensis infection, Hawaii, January 2001–February 2005

Diagnosis Inclusionary criteria Exclusionary criteria
EM Had lumbar puncture (LP) during January 2001–February 2005*

Not in Hawaii during exposure period†
Had any of the following:‡
Leukocytes or eosinophils in CSF below inclusionary
levels after adjusting for presence of erythrocytes Grossly bloody CSF
Diagnosis or signs (e.g., CSF, radiologic) of
 intracranial hemorrhage
Had cerebrospinal fluid (CSF) with both:
>6 leukocytes per mm3
Eosinophil percentage (of leukocyte count) or absolute
eosinophil count >10
A. cantonensis infection Met criteria for EM
Had intracranial hardware when LP was performed
Met parasitologic or clinical criteria for A. cantonensis infection:
Parasitologic: A. cantonensis larvae or young adult 
 worms in CSF
Clinical: manifestations compatible with A. cantonensis 
 infection and including >2 symptoms/signs§ Was <2 mo of age when LP was performed
Had been hospitalized from birth through time of LP
Had another possible cause of EM identified

*If a patient had >1 LP, the LP considered in the analyses was the one that met criteria for EM and had the highest absolute eosinophil count.
†The exposure period was defined as the 45-d period before the symptom-onset date (if unknown, the date of the LP).
‡Potential cases of EM were excluded if the eosinophilic pleocytosis was potentially attributable to blood and thus was difficult to evaluate (e.g., traumatic LP, grossly bloody CSF, or intracranial hemorrhage). For CSF specimens with >500 erythrocytes/mm3, the leukocyte and eosinophil criteria had to be met after using a correction ratio of a decrease of 1 leukocyte for every 500 erythrocytes.
§The symptoms and signs included headache, neck stiffness or nuchal rigidity, visual disturbance, photophobia or hyperacusis, cranial nerve abnormality (e.g., palsy), abnormal skin sensation (e.g., paresthesia, hyperesthesia), sensory deficit, nausea or vomiting, documented fever, increased irritability (if <4 y of age), and bulging fontanelle (if <18 mo of age).

Main Article

1Current affiliation: Emory University, Atlanta, Georgia, USA

2Current affiliation: Stanford University School of Medicine, Stanford, California, USA

Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.